Myriad Genetics (NASDAQ: MYGN) director granted 59,701 restricted stock units in equity award

Rhea-AI Filing Summary

Kumar Rashmi reported acquisition or exercise transactions in this Form 4 filing.

MYRIAD GENETICS INC director Rashmi Kumar received an equity grant of 59,701 restricted stock units (RSUs) of common stock. The RSUs were granted at no cash cost and bring Kumar’s direct holdings to 186,889 shares. Each RSU represents a contingent right to receive one share of common stock and will vest on the earlier of the first anniversary of the grant date or the company’s next annual stockholder meeting.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kumar Rashmi

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	59,701	$0.00	--

Holdings After Transaction: Common Stock — 186,889 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 59,701 shares Grant price: $0.0000 per share Holdings after grant: 186,889 shares +2 more

5 metrics

RSUs granted 59,701 shares Restricted stock units of common stock granted to director

Grant price $0.0000 per share RSUs granted at no cash cost to the director

Holdings after grant 186,889 shares Total direct common stock holdings after RSU award

Transaction date 2026-06-04 Date of RSU grant reported on Form 4

Transaction code A Grant, award, or other acquisition of common stock

Key Terms

restricted stock units, contingent right, vests, Equity Incentive Plan

4 terms

restricted stock units financial

"Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock"

vests financial

"and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting"

Equity Incentive Plan financial

"granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kumar Rashmi

(Last) (First) (Middle)

322 NORTH 2200 WEST

(Street)

SALT LAKE CITY UTAH 84116

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MYRIAD GENETICS INC [ MYGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/04/2026		A		59,701(1)	A	$0	186,889	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.

Remarks:

	By: Justin Hunter For: Rashmi Kumar	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Rashmi Kumar acquire in the latest MYGN Form 4 filing?

Rashmi Kumar received a grant of 59,701 restricted stock units of MYRIAD GENETICS INC common stock. These RSUs are part of the company’s 2026 Employee, Director and Consultant Equity Incentive Plan and were granted as equity compensation rather than a market purchase.

How do the new RSUs affect Rashmi Kumar’s total MYGN share holdings?

Following the RSU grant, Rashmi Kumar’s direct holdings increased to 186,889 shares of MYRIAD GENETICS INC common stock. This total reflects the new award and shows the director’s overall equity position as reported in the Form 4 filing.

When do Rashmi Kumar’s newly granted MYGN restricted stock units vest?

The restricted stock units vest upon the earlier of two events: the first anniversary of the grant date or the date of the next annual meeting of stockholders. Vesting must occur before shares of MYRIAD GENETICS INC common stock are actually delivered.

What does each restricted stock unit in the MYGN grant represent?

Each restricted stock unit represents a contingent right to receive one share of MYRIAD GENETICS INC common stock. Shares are only issued when vesting conditions are satisfied, meaning the award is currently a promise of future stock rather than immediately issued shares.

Was cash paid for the MYGN restricted stock units granted to Rashmi Kumar?

No cash was paid for the RSUs; the Form 4 shows a price of $0.0000 per share. This indicates the 59,701 restricted stock units were awarded as equity compensation under the company’s 2026 Employee, Director and Consultant Equity Incentive Plan.

Under which plan were Rashmi Kumar’s MYGN restricted stock units granted?

The RSUs were granted under MYRIAD GENETICS INC’s 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. This plan governs equity awards such as restricted stock units to employees, directors, and consultants of the company.